Join the Meeting Place for Moms!
Talk to other moms, share advice, and have fun!

(minimum 6 characters)

4 Bumps

FDA considers revoking approval of Avastin for advanced breast cancer

Yes, it's expensive, do you think they should do it to save money as they are considering?

Link text

Answer Question

Asked by itsmesteph11 at 2:41 PM on Sep. 24, 2010 in Politics & Current Events

Level 39 (113,405 Credits)
Answers (9)
  • If the drug is only being used as a last resort with minimal additions to life expectancy,I would say keep the drug available to only those who request it and can pay for it. No insurance provider should have to pay for this drug IMO. We are all going to die one day,whether it be from cancer or something else. I can't say that the medical profession has done us any favors by creating such a huge geriatric population. It's all perceptive I suppose, which is why I say the choice should be left to the patient.

    Answer by jewjewbee at 2:47 PM on Sep. 24, 2010

  • Cost should NOT be a consideration. I see that effectiveness IS a consideration too.

    Answer by gdiamante at 2:48 PM on Sep. 24, 2010

  • So whats effective and who decides?

    Comment by itsmesteph11 (original poster) at 2:50 PM on Sep. 24, 2010

  • The drug is really just a last ditch effort to prolong life in patients who chose it and can afford it, the side effects if and when they occur are also life threatening and provide a horrible way to die. No stave fro sure from dying from the primary cancer. Ultimately, the doctors will decide whether or not to give it to a patient, if a patient simply asks for it that does not mean they will get it. They can only request it when offered as an alternative treatment to what they are currently under. It's sad, but it's reality. The real problem and solution lies with what the drug manufacturer admits-The price is necessary to pay for continual research to perfect the drug and continue to do reasearch in other drugs with angiogenesis inhibiting characteristics.

    Answer by jewjewbee at 2:57 PM on Sep. 24, 2010

  • So whats effective and who decides?

    Therein lies the question .

    Answer by Izsarejman at 5:54 PM on Sep. 24, 2010

  • Rescinding the approval isn't going to save the FDA any money, and it isn't likely to save the government any money, either.

    Who decides if it is effective? The advisory panel at the FDA, based on the follow-up studies provided by the drug manufacturer. that is part of the deal with these fast-track drugs. There have to be follow up studies and a review of the approval based on the outcome of the follow up studies. In this case, there isn't any data to prove that the use of the drug is prolonging life or increasing quality of life. That's what the FDA will base their decision on. Not money.

    Answer by science_spot at 8:38 PM on Sep. 24, 2010

  • It's only too expensive if it's someone else that's dying.

    Answer by lovinangels at 8:39 PM on Sep. 24, 2010


    There are questions as to its safety and effectiveness and since it is a "drug of last resort" anyway, do we really NEED it?It can be a drug for all types of cancer too---not just breast cancer. I don't think the COST has anything to do with it. You know that HIV-AIDS drugs are horribly expensive but they DO WORK! The issue is WILL AVastin work? ANd is it safe?
    READ the Link

    Answer by gertie41 at 10:53 PM on Sep. 24, 2010

  • Good point, Gertie! I think that women's health issues tend to get placed on the back burner too often. Many other medications are very expensive but are covered, like my Grandfather's gleevec for leukemia or my cousin's M.S. medications.

    Answer by Iamgr8teful at 11:40 PM on Sep. 24, 2010

Join CafeMom now to contribute your answer and become part of our community. It's free and takes just a minute.